Gene · 2101
Papers2,737
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,737
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Crosstalk between corepressor NRIP1 and cAMP signaling on adipocyte thermogenic programming. | Mol Metab | 2023 | 37482187 | PubTator, text mining | PubMed |
| Expression and function of estrogen receptors and estrogen-related receptors in the brain and their association with Alzheimer's disease. | Front Endocrinol (Lausanne) | 2023 | 37469978 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing analysis of the temporomandibular joint condyle in 3 and 4-month-old human embryos. | Cell Biosci | 2023 | 37468984 | PubTator, text mining | PubMed |
| Transcriptional regulation of amino acid metabolism by KDM2B, in the context of ncPRC1.1 and in concert with MYC and ATF4. | bioRxiv | 2023 | 37461630 | PubTator, text mining | PubMed |
| Role of insulin-like growth factor 1 (IGF1) in the regulation of mitochondrial bioenergetics in zebrafish oocytes: lessons from in vivo and in vitro investigations. | Front Cell Dev Biol | 2023 | 37457295 | PubTator, text mining | PubMed |
| Continuous enzyme activity assay for high-throughput classification of histone deacetylase 8 inhibitors. | Explor Target Antitumor Ther | 2023 | 37455831 | PubTator, text mining | PubMed |
| The mutational landscape of a US Midwestern breast cancer cohort reveals subtype-specific cancer drivers and prognostic markers. | Hum Genomics | 2023 | 37454130 | PubTator, text mining | PubMed |
| In Vitro Effects of Combining Genistein with Aromatase Inhibitors: Concerns Regarding Its Consumption during Breast Cancer Treatment. | Molecules | 2023 | 37446555 | PubTator, text mining | PubMed |
| Mitochondria Deregulations in Cancer Offer Several Potential Targets of Therapeutic Interventions. | Int J Mol Sci | 2023 | 37445598 | PubTator, text mining | PubMed |
| Emerging roles of noncoding RNAs in human cancers. | Discov Oncol | 2023 | 37439905 | PubTator, text mining | PubMed |
| Innovative breakthroughs facilitated by single-cell multi-omics: manipulating natural killer cell functionality correlates with a novel subcategory of melanoma cells. | Front Immunol | 2023 | 37435067 | PubTator, text mining | PubMed |
| HLA-DQA1 expression is associated with prognosis and predictable with radiomics in breast cancer. | Radiat Oncol | 2023 | 37434241 | PubTator, text mining | PubMed |
| Functional Role of RBP in Osteosarcoma: Regulatory Mechanism and Clinical Therapy. | Anal Cell Pathol (Amst) | 2023 | 37426488 | PubTator, text mining | PubMed |
| Genetically Engineered Triple MAPT-Mutant Human-Induced Pluripotent Stem Cells (N279K, P301L, and E10+16 Mutations) Exhibit Impairments in Mitochondrial Bioenergetics and Dynamics. | Cells | 2023 | 37408218 | PubTator, text mining | PubMed |
| Melanoma-intrinsic NR2F6 activity regulates antitumor immunity. | Sci Adv | 2023 | 37406115 | PubTator, text mining | PubMed |
| Single amino acid-based PROTACs trigger degradation of the oncogenic kinase BCR-ABL in chronic myeloid leukemia (CML). | J Biol Chem | 2023 | 37392851 | PubTator, text mining | PubMed |
| Upregulation of dihydropyrimidinase-like 3 (DPYSL3) protein predicts poor prognosis in urothelial carcinoma. | BMC Cancer | 2023 | 37380971 | PubTator, text mining | PubMed |
| Docosahexaenoic Acid as Master Regulator of Cellular Antioxidant Defenses: A Systematic Review. | Antioxidants (Basel) | 2023 | 37372014 | PubTator, text mining | PubMed |
| Cancer stem cell fate determination: mito-nuclear communication. | Cell Commun Signal | 2023 | 37370081 | PubTator, text mining | PubMed |
| Sex and age differences in AMPK phosphorylation, mitochondrial homeostasis, and inflammation in hearts from inflammatory cardiomyopathy patients. | Aging Cell | 2023 | 37365150 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2101/papers?page=15